Company page
Alphamab Oncology
Alphamab Oncology is a public company listed on the Hong Kong Stock Exchange under the ticker 9966. The company focuses on developing innovative therapies for cancer treatment. As of now, Alphamab Oncology has a market capitalization of approximately HKD 894.97 million.
- Ticker
- 9966:HKEX
- Asset type
- Stock
- Market cap
- $895.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD